Benitec Biopharma Inc. (BNTC) stock
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.15−0.39 (-4.57%)
Close on Nov 17, 2026Market cap $284.29MP/E –Yield –
Benitec Biopharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Benitec Biopharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$16.52M. For fiscal 2026 it was -$16.52M. The highest annual figure on record is $4.79M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$16.52M | – |
| FY2025 | Jun 30, 2025 | -$23.59M | – |
| FY2024 | Jun 30, 2024 | -$19.40M | – |
| FY2023 | Jun 30, 2023 | -$18.01M | – |
| FY2022 | Jun 30, 2022 | -$15.90M | – |
| FY2021 | Jun 30, 2021 | -$12.83M | – |
| FY2020 | Jun 30, 2020 | -$7.54M | -257.3% |
| FY2019 | Jun 30, 2019 | $4.79M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$4.94M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$4.45M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$3.78M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$3.35M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$8.21M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$3.09M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$7.70M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$4.59M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$3.29M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$6.17M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$5.37M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$4.58M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$4.10M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$4.03M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$5.84M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$4.05M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$4.86M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$3.42M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$3.34M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$4.28M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$5.16M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$1.99M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$3.33M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$2.36M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$3.15M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$769.00K | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$3.08M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$545.00K | – |
See a number that looks wrong?